This document appears to be a template for presenting an investment opportunity to OTAF's Investment Screening Committee. It includes placeholders for company details like name, address, presenter contact information, as well as disclaimers about securities, projections, and forward-looking statements. The template then has sections for the company description, the problem being solved, market details, competition, barriers to entry, sales and marketing plan, business model, team, current status, financial overview, regulatory issues if applicable, details on the current funding round, capital access plan, liquidity event expectations, and why the company wants to partner with OTAF.

1. Your Company (C Corp)
(n.b.: OTAF only invests in C Corps in order to take advantage of QSBS tax treatment)
Date of OTAF’s Investment Screening
Committee meeting
Mailing Address/website
Presenter’s contact info

2. Securities Disclaimer
[EXAMPLE LANGUAGE BELOW IS NOT LEGAL ADVICE. PLEASE CONSULT YOUR LEGAL
COUNSEL ON APPROPRIATE STEPS TO TAKE AND DISCLAIMER LANGUAGE TO INCLUDE]
The information presented in this presentation
is not intended to be, and should not be
construed as, an offer to sell any security or a
solicitation of an offer to buy any security. Any
such offer or sale will be made pursuant to, and
the information presented at this meeting is
qualified in its entirety by, authorized offering
documents and related disclosure schedules or
similar disclosure documentation.

3. Projections Disclaimer
[EXAMPLE LANGUAGE BELOW IS NOT LEGAL ADVICE. PLEASE CONSULT YOUR LEGAL
COUNSEL ON APPROPRIATE STEPS TO TAKE AND DISCLAIMER LANGUAGE TO INCLUDE]
• TERMS SUCH AS “BELIEVE,”, “FORECAST”, “ESTIMATE”, AND
“PROJECT” AS USED IN THIS PRESENTATION AND IN RELATED
MATERIALS ARE FORWARD-LOOKING STATEMENTS AND
ILLUSTRATIONS BASED ON VARIOUS ASSUMPTIONS AND
PERFORMANCE ESTIMATES. ALTHOUGH SUCH FINANCIAL
PRESENTATIONS AND PROJECTIONS ON ASSUMPTIONS AND
CALCULATIONS DEEMED REASONABLE, THEY COULD PROVE TO BE
INACCURATE DUE TO ECONOMIC CLIMATE, COMPETITIVE AND
MARKET CHANGES AND CONDITIONS, RISK FACTORS AND
EVOLVING BUSINESS DECISIONS, OR OTHER FACTORS WHICH ARE
DIFFICULT OR IMPOSSIBLE TO PREDICT. THERE IS NO ASSURANCE
THAT THE FINANCIAL CIRCUMSTANCES OR RESULTS ILLUSTRATED
OR CONTEMPLATED BY SUCH STATEMENTS AND PROJECTIONS
COULD OR WOULD BE REALIZED.

4. Company Description & Status
Year founded & 1-2 sentences: e.g. “We founded XYZ
in 2008 as a medical device company to commercialize
uniquely effective wound treatment appliances. We
have a working prototype and have filed our 510(k)
application.”

5. The Problem/Pain You Solve
(in 1–2 sentences)
Crisply explain the problem you solve. What is your solution & USP (Unique
Selling Proposition)? Is it “Better/Faster/Cheaper” or a “Brave New
World/Disruptive Technology?” Do you enable your customers to cut costs or
generate more revenues? Are you selling a vitamin pill or an aspirin? What’s the
current pain level, the inability of others to relieve it, and the cost of the pain in
terms of dollars/time/inconvenience? Is buying your product/service an
additive cost or does it replace other costs? If not solving a problem, then how
unique and essential is the thrilling customer experience you plan to provide?
Why is now a great time for your venture to be successful?

6. Your Market
Dimension your Total Global Market Size (i.e. with a 100% capture
rate) & Growth Rate; Data from third party research organizations?
Your Total Available Market (separate US & foreign); Your initial
Targeted Market; What % capture is needed for Survival Cash Flow
Break Even? How much capture is needed to attract TSB’s
(Targeted Strategic Bidders)?

7. Your Competition
Their Size: If public, provide their Ticker symbol; If private,
provide estimated revenues and amount/names of VC
funding (if any); Their solutions & business model; Why is
yours so superior? What’s your unique and unfair
competitive advantage? Why is it sustainable? Presuming
your toughest competitor has adequate funding to replicate
your idea, how long will it take them to do so? What might
be their combative reaction when they see your success?

8. Barriers to Entry/
Copying/Knock-offs
Your IP & filing status; owned by you or licensed?
Other protections and barriers? Explain the
difficulty and likelihood that your product can be
knocked off in China (disregarding all IP laws).
Mention your IP counsel’s contact info.

9. Your Sales & Marketing Plan
Direct Sales force? Channel Strategy? If selling through
distributors, who has managed such channel partners in the past?
What’s your typical sales cycle? Planned staffing levels w/ goals &
compensation per FTE; explain CAC (Client Acquisition Cost) vs.
LTV (Lifetime Value); Why will prospects buy? Who must get into
whose office and say what how many times before they buy?
Typical customer’s purchase approval process? Is an off budget
purchase decision likely? Any seasonality due to budgeting?

10. Your Business Model
Sell @ what price? Pricing Strategy; Disposables?
Maintenance fees? Contract expiry? Must be in
budget? Your recurring revenues? Leasing Option?
How many of your products do they need? Accounts
Receivable or Credit Card? Payment cycle/working
capital model? Average account/sale size?

11. Your Team (names in green have
invested cash to date)
Management’s relevant experience
(companies/titles/years); prior exit success; If VC
funding is required, explain team’s VC contacts and
past success in making money for them; BOD;
Advisors; Professional Service Providers

12. Your Current Status
Sales to date (in # of units, clients, & not
just revenue $); Strategic/channel partners?
Marquee customers? Testimonials?
Compare pipeline to sales needed to achieve
CFBE; Likely closure rate?

13. Financial Overview
Current Balance Sheet (cash + A/R); Monthly Burn Rate & Months to Fumes;
Executives’ Current Cash Compensation; last month’s revenues; 3-yr. forecasts
showing units & EBITDA*; If post revenues, state # of units and customers; Sales
success needed to achieve Survival CFBE (in # of units & customers)
[PLEASE CONSULT YOUR COUNSEL ON APPROPRIATE STEPS TO TAKE AND
DISCLAIMER LANGUAGE TO INCLUDE REGARDING ANY FORWARD LOOKING
STATEMENTS]

14. Regulatory Issues (Add this slide
if appropriate)
If Regulatory Approval is needed prior to
commencing sales, discuss the pathway &
advisor (For healthcare ventures discuss
510(k) or CE Mark; Reimbursement Path &
Advisor)

15. This Round
Equity being sold @ what valuation? What %
uptick since prior round? Pro Forma Cap Table;
OTITC status (If applicable); Syndication Need; Coinvestors approached? Use of Proceeds (not just
how spent, but the milestones achieved prior to
next round);

16. Your Capital Access Plan
Total dilutive and non-dilutive capital needed “From
Here to Liquidity;” Future rounds: $, milestones and
valuation for each tranche; Other sources
(SBIR/NIH/GCIC/IOLF) ; When do Survival &
Sustainable CFBE occur (month/units/customers)?; Is
VC funding needed for an exit?

17. Your Liquidity Event
Discuss 5 most likely TSB’s (Targeted Strategic Bidders);
Which are the most critical TSC’s (Targeted Strategic
Customers)? What’s the range of “months & money
needed from today until the M & A exit?”; Is putting
$3 -5 MM in the founders’/CEO’s pocket in 3 – 5 years
likely? Is that an acceptable exit?

18. Why do you want OTAF to back
your venture?
What non-cash assistance do you expect
from OTAF? Will this round have two
Director seats? Need OTAF’s syndication
help? Explain next steps and the timeline to
the initial and final closes for this round

19. Questions?
Same contact information as on first
slide